Clopidogrel + Domperidone Granules

Combination Therapy • Granules

Dual-component granules combining platelet inhibition with prokinetic support for specialised cardiovascular-gastrointestinal regimens.

  • GradeIP / BP / USP / EP
  • Pack Size25/50 kg
  • CertificationsWHO-GMP • ISO 9001

Product overview

Domperidone is a dopamine D2-receptor antagonist with prokinetic and anti-emetic action, often combined with PPIs for reflux with delayed gastric emptying.

Clopidogrel is a P2Y12 antiplatelet agent used to prevent heart attack and stroke, often alongside aspirin in dual antiplatelet therapy.

Pharmaceutical granules improve the flow and compressibility of an active ingredient so that tablet presses run with consistent weight and content uniformity.

Pharmaceutical applications

  • Tablet manufacturing for gastro-prokinetic products.
  • Reducing in-house granulation steps and batch cycle time.
  • Formulation development, scale-up and commercial supply programmes.

Product specifications

Product
Clopidogrel + Domperidone Granules
Form
Granules
Therapeutic category
Combination Therapy
Strength
Agreed per project — share your target strength in the enquiry
Grade
IP / BP / USP / EP
Pack size
25/50 kg
Site certifications
WHO-GMP, ISO 9001, ISO 14001

Detailed specifications, COA and technical documentation are shared on request.

Supply and enquiries

Rraynex supplies Clopidogrel + Domperidone Granules to pharmaceutical manufacturers, formulation developers and CDMOs in 25/50 kg packs with batch traceability. Send your quantity, grade and documentation needs through the enquiry form and the commercial team will reply with specifications and a quotation. Rraynex is a B2B supplier and does not sell to consumers.

Send product enquiry Browse all granules Manufacturing capabilities

Other Domperidone products from Rraynex

Frequently asked questions

Enquire Now